Current conditions and significance of outpatient cardiac rehabilitation and home nursing-care services in heart failure patients with mid-range or preserved ejection fraction: post-hoc analysis of the REAL-HF registry

2021 ◽  
Author(s):  
Toshiro Kitagawa ◽  
Takayuki Hidaka ◽  
Noriaki Watanabe ◽  
Makiko Naka ◽  
Mizuho Yamaguchi ◽  
...  
Keyword(s):  
Heart Failure ◽  
Ejection Fraction ◽  
Nursing Care ◽  
Preserved Ejection Fraction ◽  
Home Nursing ◽  
Heart Failure Patients ◽  
Post Hoc Analysis ◽  
Care Services ◽  
Post Hoc ◽  
Home Nursing Care

scholarly journals Serum potassium and outcomes in heart failure with preserved ejection fraction: a post‐hoc analysis of the PARAGON‐HF trial

2021 ◽  
Author(s):  
João Pedro Ferreira ◽  
Brian L. Claggett ◽  
Jiankang Liu ◽  
Akshay S. Desai ◽  
Marc A. Pfeffer ◽  
...  
Keyword(s):  
Heart Failure ◽  
Ejection Fraction ◽  
Serum Potassium ◽  
Preserved Ejection Fraction ◽  
Post Hoc Analysis ◽  
Post Hoc

Galectin-3 in Heart Failure – Linking Fibrosis, Remodelling and Progression

2010 ◽  
Vol 6 (2) ◽  
pp. 33 ◽  
Author(s):  
Christopher R deFilippi ◽  
G Michael Felker ◽  
◽  
Keyword(s):  
Heart Failure ◽  
Ejection Fraction ◽  
Risk Stratification ◽  
Cardiac Fibrosis ◽  
The Elderly ◽  
Preserved Ejection Fraction ◽  
Heart Failure Patients ◽  
Large Populations ◽  
Galectin 3

For many with heart failure, including the elderly and those with a preserved ejection fraction, both risk stratification and treatment are challenging. For these large populations and others there is increasing recognition of the role of cardiac fibrosis in the pathophysiology of heart failure. Galectin-3 is a novel biomarker of fibrosis and cardiac remodelling that represents an intriguing link between inflammation and fibrosis. In this article we review the biology of galectin-3, recent clinical research and its application in the management of heart failure patients.

Sign in / Sign up

Export Citation Format

Share Document